Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 - DRAGON PHARMACEUTICAL INC | dragon10k091231.htm |
| EX-32 - SOX SECTION 906 CEO AND CFO CERTIFICATIONS - DRAGON PHARMACEUTICAL INC | exhibit32.htm |
| EX-23.2 - CONSENT OF ERNST & YOUNG LLP - DRAGON PHARMACEUTICAL INC | exhibit23-2.htm |
| EX-31.2 - SOX SECTION 302 CFO CERTIFICATION - DRAGON PHARMACEUTICAL INC | exhibit31-2.htm |
| EX-31.1 - SOX SECTION 302 CEO CERTIFICATION - DRAGON PHARMACEUTICAL INC | exhibit31-1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-55794) pertaining to Stock Options Granted to Directors, Technical Advisors, and Employees under Stock Option Agreements of our report dated March 25, 2009, with respect to the consolidated financial statements of Dragon Pharmaceutical Inc. included in the Annual Report (Form 10-K) for the year ended December 31, 2009
|
Vancouver, Canada |
/s/ Ernst & young LLP |